Debiopharm International SA acquires FibroTrap sample processing technology from Spinomix

Debiopharm International SA acquires FibroTrap sample processing technology from Spinomix

Lausanne, Switzerland – June 16, 2015 – Debiopharm International SA (Debiopharm), part of Debiopharm Group™, a Swiss-based global biopharmaceutical company, and Spinomix, a Swiss technology platform company providing innovative sample processing solutions to the life sciences sector, today announced the acquisition by Debiopharm of Spinomix’ FibroTrap sample processing technology. Commercial terms of the transaction were not disclosed.

Read more on Debiopharm’s website…

Read the article in Le Temps (French only)

Useful links: